Restylane Refyne and Restylane Defyne are dermal fillers injected under the facial skin. Once injected, the products help smooth away the wrinkles and folds that may form around the sides of a patient’s nose and corners of the mouth, according to a news release.
Restylane Refyne was approved to treat moderate to severe facial wrinkles and Restylane Defyne was approved to treat deeper facial wrinkles.
Fort Worth, Texas-based Galderma developed the products.
More articles on supply chain:
JHL Biotech signs $236M biosimilar deal with Sanofi
Naloxone price hikes could hurt efforts to reduce opioid-related deaths in US
Trump administration will likely repeal Medical Device Tax: 5 takeaways
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
